Having your blood drawn for a diagnostic or screening exam isn’t anyone’s favorite way to spend part of the day. If this will be your first time, you may feel anxious about what to expect. Medical procedures involving needles are a well-known fear to many,...
Published on: February 28, 2018 (WASHINGTON, February 28, 2018) — Today, Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018. This legislation will authorize a program within the Centers for Disease Control and Prevention (CDC) that...
Published on: April 17, 2018 (WASHINGTON, April 18, 2018) — Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study. The study, published online today in Blood Advances, a journal of...
Publish date: June 7, 2018 By Christopher Palmer Hematology News The Food and Drug Administration has approved methoxy polyethylene glycol-epoetin beta (Mircera) for the treatment of dialysis-related anemia in pediatric patients aged 5-17 years with chronic kidney disease whose hemoglobin had been stabilized with an erythropoiesis-stimulating agent (ESA). The approval for this long-acting...